Trial Profile
Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect of Aging of Multiple Oral Doses of GLPG1205 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2022
Price :
$35
*
At a glance
- Drugs GLPG 1205 (Primary)
- Indications Idiopathic pulmonary fibrosis; Inflammatory bowel diseases
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Galapagos NV
- 06 Apr 2017 New trial record